> Titan Pharmaceuticals announced it was launching a Phase III trial for opioid independence but discontinued a Phase II trial of an experimental therapy for CHF without explanation. Report
> South San Francisco-based Poniard has secured a $15 million loan. Release
> Bilcare has acquired DHP, a UK-based clinical trials service provider. Report
> Insert Therapeutics has completed a $10 million private placement. Release
> Evolutec has raised 2.8 million stg in a private placement. Report
> Millennium Pharmaceuticals discussed plans to focus on Velcade and pipeline development in its latest quarterly report. Report
> The FDA has signed off on Human Genome Sciences Phase III trial of LymphoStat-B. Report
And Finally... Researchers are studying the use of fat stem cells for breast reconstruction. Release